Clinicopathologic features of invasive breast cancer (BC) diagnosed in carriers of germline PALB2, CHEK2 and ATM pathogenic variants.

被引：0
|
作者：
Scott, Danika
Kingham, Kerry
Hodan, Rachel
Ma, Cindy
Mills, Meredith
Ford, James M.
Kurian, Allison W.
Telli, Melinda L.
机构：
[1] Stanford Univ, Sch Med, Stanford, CA USA
[2] Stanford Univ, Stanford Canc Inst, Sch Med, Stanford, CA USA
[3] Stanford Hlth Care, Stanford, CA USA
[4] Stanford Univ, Sch Med, Stanford Canc Inst, Palo Alto, CA 94304 USA
[5] Stanford Univ, Stanford, CA 94305 USA
[6] Stanford Sch Med, Stanford, CA 94305 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2020年 / 38卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1549
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Hereditary breast cancer beyond BRCA: Clinical and histopathological characteristics in patients with germline CHEK2, ATM, PALB2 and TP53-mutations
    Hoste, G.
    D'Hoore, P.
    Legius, E.
    Van Buggenhout, G.
    Floris, G.
    Wildiers, H.
    Han, S. N.
    Van Nieuwenhuysen, E.
    Berteloot, P.
    Smeets, A.
    Nevelsteen, I.
    Weltens, C.
    Janssen, H.
    Van Limbergen, E.
    Neven, P.
    Punie, K.
    CANCER RESEARCH, 2019, 79 (04)
  • [32] Diagnosis, management, and surveillance for patients with PALB2, CHEK2, and ATM gene mutations
    Krupa, Kelly
    Kowzun, Maria
    Potdevin, Lindsay
    Kumar, Shicha
    Eladoumikdachi, Firas
    Fencer, Maria
    Bleich, Gabrielle
    ANNALS OF SURGICAL ONCOLOGY, 2022, 29 (SUPPL 1) : 143 - 143
  • [33] Erratum to: Evaluation of variants in the CHEK2, BRIP1 and PALB2 genes in an Irish breast cancer cohort
    N. M. McInerney
    N. Miller
    A. Rowan
    G. Colleran
    E. Barclay
    C. Curran
    M. J. Kerin
    I. P. Tomlinson
    E. Sawyer
    Breast Cancer Research and Treatment, 2012, 131 : 729 - 729
  • [34] Diagnosis, Management, and Surveillance for Patients With PALB2, CHEK2, and ATM Gene Mutations
    Fencer, Maria G.
    Krupa, Kelly A.
    Bleich, Gabrielle C.
    Grumet, Sherry
    Eladoumikdachi, Firas G.
    Kumar, Shicha
    Kowzun, Maria J.
    Potdevin, Lindsay B.
    CLINICAL BREAST CANCER, 2023, 23 (04) : E194 - E199
  • [35] CHEK2 Pathogenic Germline Variants in Patients With NSCLC
    Sorscher, Steven
    JTO CLINICAL AND RESEARCH REPORTS, 2022, 3 (12):
  • [36] Frequency of Pathogenic Germline Variants in CDH1, BRCA2, CHEK2, PALB2, BRCA1, and TP53 in Sporadic Lobular Breast Cancer
    Petridis, Christos
    Arora, Iteeka
    Shah, Vandna
    Moss, Charlotte L.
    Mera, Anca
    Clifford, Angela
    Gillett, Cheryl
    Pinder, Sarah E.
    Tomlinson, Ian
    Roylance, Rebecca
    Simpson, Michael A.
    Sawyer, Elinor J.
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2019, 28 (07) : 1162 - 1168
  • [37] Histologic and Molecular Subtype of CHEK2 and PALB2 Associated Breast Cancers
    Agarwal, Indu
    Sullivan, Megan E.
    LABORATORY INVESTIGATION, 2018, 98 : 43 - 43
  • [38] Frequency of pathogenic germline mutation in CHEK2, PALB2, MRE11, and RAD50 in patients at high risk for hereditary breast cancer
    Haeyoung Kim
    Dae-Yeon Cho
    Doo Ho Choi
    Mijin Oh
    Inkyung Shin
    Won Park
    Seung Jae Huh
    Seok Jin Nam
    Jeong Eon Lee
    Seok Won Kim
    Breast Cancer Research and Treatment, 2017, 161 : 95 - 102
  • [39] 21-gene recurrence score results according to germline pathogenic variants in BRCA1, BRCA2, PALB2, ATM, CHEK2 and Lynch Syndrome genes
    Kurian, Allison W.
    Abrahamse, Paul
    Ward, Kevin
    Hamilton, Ann S.
    Deapen, Dennis
    Shak, Steven
    Katz, Steven J.
    CANCER RESEARCH, 2020, 80 (04)
  • [40] Frequency of pathogenic germline mutation in CHEK2, PALB2, MRE11, and RAD50 in patients at high risk for hereditary breast cancer
    Kim, Haeyoung
    Cho, Dae-Yeon
    Choi, Doo Ho
    Oh, Mijin
    Shin, Inkyung
    Park, Won
    Huh, Seung Jae
    Nam, Seok Jin
    Lee, Jeong Eon
    Kim, Seok Won
    BREAST CANCER RESEARCH AND TREATMENT, 2017, 161 (01) : 95 - 102
12345